Global AI customer targeting platform PeakData raises £10m Series A funding
Funding News
Posted
PeakData, a global AI customer targeting platform, raises £10m to help pharmaceutical companies identify most relevant and impactful healthcare professionals
PeakData, the AI platform that identifies and collates the most relevant
and impactful healthcare professionals (HCPs) for pharmaceutical companies, has
raised £10m in a Series A funding round led by AlbionVC and including
Octopus Ventures and Heal Capital.
Founded in 2018 by data scientists Patrick De Boer and Michael Feldman, the startup enables pharmaceutical companies to enhance the depth and breadth of their customer base and learn more about HCPs that are most relevant to their target market, and in turn, ensure patients benefit from innovative new medicines much sooner.
The Series A funding follows rapid 6x growth for the company in 2021. PeakData’s platform is now being used by over half of Europe’s largest pharmaceutical companies and the company has grown from 12 to 70 employees since 2021.
“When we first met Patrick, Michael and the team, we were impressed by their dedication, drive and determination to develop the best data AI platform in a healthcare setting. Finding the right therapeutic experts and healthcare professionals for their medicines is massively important for pharmaceutical companies and with PeakData they can now reach global, national, and local medical professionals who shape clinical decision-making. The potential for PeakData to help provide better patient outcomes and improve the decision-making of key healthcare professionals is very exciting and we’re pleased to be able to join the team on this journey.”
CHRISTOPH RUEDIG, PARTNER
PeakData’s platform is fully customisable to the needs of each of its customers with tailored onboarding and training to support rapid deployment across a business.
Congratulations to Patrick De Boer and Michael Feldman, and the whole team at PeakData.
Eu Startups has more here.